Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon + Dexmedetomidine vs Sevoflurane for Prevention of Emergence Delirium After Pediatric Cardiac Catheterization
2018-002258-56Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2018
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in Emergence agitation (EA) comparing Xenon + Dexmedetomidine anesthesia with Sevoflurane anesthesia (2 arms). Primary endpoint: Incidence of emergence delirium. Started Jun 2018; status: completed.
02
Drugs
dexmedetomidinexenonsevoflurane
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on 2018-002258-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002258-56.